Technician freezes cell lines in BCG vaccine study

Technician freezes cell lines in BCG vaccine study

G255/0109 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 26.2MB

Downloadable file size: 1.8MB

Price image Pricing

Please login to use the price calculator


This image is part of the feature Tb Vaccine

Credit: H. RAGUET/EURELIOS/SCIENCE PHOTO LIBRARY

Caption: BCG vaccine research. Technician in gloves and mask inserts cell lines into a cylinder of liquid nitrogen. The cells are for research into a DNA BCG (bacille Calmette-Guerin) vaccine against TB (tuberculosis). A DNA vaccine consists of purified DNA that codes for a disease antigen. Professor Content and Dr Huygen at the Brussels Pasteur Institute have developed a vaccine that codes for antigen 85 extracted from BCG. Here, cell lines stored at -195 degrees Celsius can be thawed, cultured & used in research when needed. A DNA BCG vaccine could be very important in the global fight against TB. Unlike traditional BCG vaccine, a DNA vaccine could also protect people with HIV.

Release details: Model release not available. Property release not required.

Keywords: bcg vaccine, bioengineered, bioengineering, biotechnology, cell line, cell storage, dna, dna research, dna vaccine, drug, drugs, genetic, genetics, liquid nitrogen, manufacture, production, research, tb, tuberculosis, tuberculosis vcn, vaccine

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.